For the first time, the top 10 cars on Consumer Reports' annual list of best new vehicles also include electric or hybrid ...

DENVER — Last fall, Consumer Reports tested dozens of protein powders and ready-to-drink shakes. What the lab found raised red flags: more than two-thirds contained more lead in one serving than CR’s ...

Having a cell phone is a necessity in the modern era. They do far more than simply make phone calls. From content creation to reporting, even the most basic smartphone can function as an all-in-one ...

Bio-Rad Laboratories, Inc. ( BIO) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST Good day, everyone, and welcome to the ...

Sadly, the days of being able to buy a brand new car for less than $20,000 are over, and the average transaction price on a new car is now north of $50,000. The good news is, used cars last far longer ...

Consumers felt a bit better about the economy in January as sentiment lifted off from near-historical lows reached late last year, according to the University of Michigan’s monthly survey. The ...

The latest findings include RNA-sequencing data showing that GRI-0621 significantly modulated genes associated with lung injury. Prior Phase 2a results had already shown favorable safety and ...

WASHINGTON, Jan 27 (Reuters) - U.S. consumer confidence slumped to the lowest level in more than 11-1/2 years in January amid mounting anxiety over a sluggish labor market and high prices, which could ...

Several people became sick from an illegal bio lab running out of a Las Vegas home that also served as an Airbnb, according to documents.

AI infrastructure demand drives memory chip price surge Smartphone and PC sales expected to decline due to higher costs Memory chip shortage impacts low- and mid-range device makers most Apple may ...

We hope the new two-row model will have a smoother launch than the EX30 and EX90. Volvo’s rebirth as a technology-first, all-electric automaker continues with the debut of the EX60. This two-row ...

Corcept Therapeutics’ relacorilant has improved overall survival (OS) in a phase 3 ovarian cancer study, building on interim data published last year and giving the biotech momentum as it heads into ...